132 related articles for article (PubMed ID: 2591384)
1. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
[TBL] [Abstract][Full Text] [Related]
2. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
3. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
Wiklund LM; Brolin I; Sjöholm K
Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
[TBL] [Abstract][Full Text] [Related]
5. Contrast media in abdominal computed tomography. A double blind clinical trial comparing a non-ionic (iohexol) and an ionic (metrizoate) contrast medium.
Skalpe IO; Ostensen HM
Eur J Radiol; 1984 Feb; 4(1):74-5. PubMed ID: 6373261
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of iopentol in healthy volunteers.
Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
[TBL] [Abstract][Full Text] [Related]
7. [Comparative evaluation of 2 non-ionic contrast media, iopentol (350 mgI/ml) and iopamidol (370 mgI/ml) in coronary angiography].
Maddestra N; Di Cesare A; Salute L; Toppetti A; Minguzzi P; Marelli C; Bonomo L
Radiol Med; 1994 Oct; 88(4):396-400. PubMed ID: 7997610
[TBL] [Abstract][Full Text] [Related]
8. Effects of ionic and non-ionic contrast media after selective peripheral and cerebral arterial injections in rats.
Mützel W; Speck U
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():62-6. PubMed ID: 6139082
[No Abstract] [Full Text] [Related]
9. Reduced side effects of low osmolality non-ionic contrast media in coronary arteriography. Comparative experimental study in dogs.
Schräder R; Baller D; Hoeft A; Korb H; Wolpers HG; Hellige G
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():67-77. PubMed ID: 6139083
[No Abstract] [Full Text] [Related]
10. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
Rathsmann P; Jacobs GF; Müller RD
Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
[TBL] [Abstract][Full Text] [Related]
11. Intravascular studies with iohexol (Omnipaque). Results from the first 49 clinical trials.
Andrew E; Dahlstrøm K; Sveen K; Hvinden G; Holager T; Mowinckel P; Renaa T; Laulund S
Eur J Radiol; 1985 Feb; 5(1):68-76. PubMed ID: 3891345
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of iohexol after injection into healthy volunteers.
Levorstad K; Kolbenstvedt A; Kolmannskog F; Sommerfelt SC; Stormorken H; Andrew E; Sveen K
Acta Radiol Diagn (Stockh); 1983; 24(3):241-51. PubMed ID: 6624528
[TBL] [Abstract][Full Text] [Related]
13. Systemic, pulmonary and renal haemodynamic effects of intravenously infused iopentol. A comparison in the pig of a new low osmolar non-ionic medium with saline and iohexol.
Sunnegårdh O; Hietala SO; Wirell S; Ekelund L
Acta Radiol; 1990 Jul; 31(4):395-9. PubMed ID: 2206697
[TBL] [Abstract][Full Text] [Related]
14. Iopentol in urography. A clinical comparison between iopentol and metrizoate including delayed reactions.
Sortland O; Johansen JG; Oksendal AN; Waaler A
Acta Radiol; 1992 Jul; 33(4):368-73. PubMed ID: 1633050
[TBL] [Abstract][Full Text] [Related]
15. Organ-specific and general tolerance of iotrolan 280 after intravenous administration: phase I study in healthy volunteers.
Staks T; Seifert W; Wenzel-Hora BI; Fuhrmeister A
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():33-8. PubMed ID: 2568805
[TBL] [Abstract][Full Text] [Related]
16. Intravenous urography with a new non-ionic contrast media in a clinical phase III study: iopentol vs iohexol.
Rasmussen F; Dyreborg U; Larsen C; Waaler A; Tove Kristofferson D
Clin Radiol; 1990 Jan; 41(1):37-41. PubMed ID: 2404650
[TBL] [Abstract][Full Text] [Related]
17. Reducing the risk of ventricular fibrillation by adding sodium to ionic and non-ionic contrast media with low iodine concentration. Coronary perfusion of the isolated rabbit heart with meglumine diatrizoate or iopentol at 140 mg I/ml and 0-154 mmol Na+/l.
Bååth L; Almén T
Acta Radiol; 1989; 30(2):207-12. PubMed ID: 2647114
[TBL] [Abstract][Full Text] [Related]
18. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
Lackner K; Köster O; von Uexküll V; Broich H
Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
[TBL] [Abstract][Full Text] [Related]
19. Contrast media and pain: hypotheses on the genesis of pain occurring on intra-arterial administration of contrast media.
Hagen B; Klink G
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():50-6. PubMed ID: 6139080
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
